Exact Mass: 473.2234006
Exact Mass Matches: 473.2234006
Found 179 metabolites which its exact mass value is equals to given mass value 473.2234006
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
CD 1790
C25H27N7O3 (473.21752720000006)
CD 1790 is a metabolite of linagliptin. Linagliptin (BI-1356, trade names Tradjenta and Trajenta) is a DPP-4 inhibitor developed by Boehringer Ingelheim for treatment of type II diabetes. Linagliptin (once-daily) was approved by the US FDA on 2 May 2011 for treatment of type II diabetes. It is being marketed by Boehringer Ingelheim and Lilly. (Wikipedia)
Ala Pro Thr Trp
Ala Pro Trp Thr
Ala Gln Gln Gln
Ala Thr Pro Trp
Ala Thr Trp Pro
Ala Trp Pro Thr
Ala Trp Thr Pro
Asp Pro Arg Ser
Asp Pro Ser Arg
Asp Arg Pro Ser
Asp Arg Ser Pro
Asp Ser Pro Arg
Asp Ser Arg Pro
Phe Asn Pro Pro
Phe Pro Asn Pro
Phe Pro Pro Asn
Ile Met Asn Pro
C20H35N5O6S (473.23079300000006)
Ile Met Pro Asn
C20H35N5O6S (473.23079300000006)
Ile Asn Met Pro
C20H35N5O6S (473.23079300000006)
Ile Asn Asn Asn
Ile Asn Pro Met
C20H35N5O6S (473.23079300000006)
Ile Pro Met Asn
C20H35N5O6S (473.23079300000006)
Ile Pro Asn Met
C20H35N5O6S (473.23079300000006)
Leu Met Asn Pro
C20H35N5O6S (473.23079300000006)
Leu Met Pro Asn
C20H35N5O6S (473.23079300000006)
Leu Asn Met Pro
C20H35N5O6S (473.23079300000006)
Leu Asn Asn Asn
Leu Asn Pro Met
C20H35N5O6S (473.23079300000006)
Leu Pro Met Asn
C20H35N5O6S (473.23079300000006)
Leu Pro Asn Met
C20H35N5O6S (473.23079300000006)
Met Ile Asn Pro
C20H35N5O6S (473.23079300000006)
Met Ile Pro Asn
C20H35N5O6S (473.23079300000006)
Met Leu Asn Pro
C20H35N5O6S (473.23079300000006)
Met Leu Pro Asn
C20H35N5O6S (473.23079300000006)
Met Asn Ile Pro
C20H35N5O6S (473.23079300000006)
Met Asn Leu Pro
C20H35N5O6S (473.23079300000006)
Met Asn Pro Ile
C20H35N5O6S (473.23079300000006)
Met Asn Pro Leu
C20H35N5O6S (473.23079300000006)
Met Pro Ile Asn
C20H35N5O6S (473.23079300000006)
Met Pro Leu Asn
C20H35N5O6S (473.23079300000006)
Met Pro Asn Ile
C20H35N5O6S (473.23079300000006)
Met Pro Asn Leu
C20H35N5O6S (473.23079300000006)
Met Pro Gln Val
C20H35N5O6S (473.23079300000006)
Met Pro Val Gln
C20H35N5O6S (473.23079300000006)
Met Gln Pro Val
C20H35N5O6S (473.23079300000006)
Met Gln Val Pro
C20H35N5O6S (473.23079300000006)
Met Val Pro Gln
C20H35N5O6S (473.23079300000006)
Met Val Gln Pro
C20H35N5O6S (473.23079300000006)
Asn Phe Pro Pro
Asn Ile Met Pro
C20H35N5O6S (473.23079300000006)
Asn Ile Asn Asn
Asn Ile Pro Met
C20H35N5O6S (473.23079300000006)
Asn Leu Met Pro
C20H35N5O6S (473.23079300000006)
Asn Leu Asn Asn
Asn Leu Pro Met
C20H35N5O6S (473.23079300000006)
Asn Met Ile Pro
C20H35N5O6S (473.23079300000006)
Asn Met Leu Pro
C20H35N5O6S (473.23079300000006)
Asn Met Pro Ile
C20H35N5O6S (473.23079300000006)
Asn Met Pro Leu
C20H35N5O6S (473.23079300000006)
Asn Asn Ile Asn
Asn Asn Leu Asn
Asn Asn Asn Ile
Asn Asn Asn Leu
Asn Asn Gln Val
Asn Asn Val Gln
Asn Pro Phe Pro
Asn Pro Ile Met
C20H35N5O6S (473.23079300000006)
Asn Pro Leu Met
C20H35N5O6S (473.23079300000006)
Asn Pro Met Ile
C20H35N5O6S (473.23079300000006)
Asn Pro Met Leu
C20H35N5O6S (473.23079300000006)
Asn Pro Pro Phe
Asn Gln Asn Val
Asn Gln Val Asn
Asn Val Asn Gln
Asn Val Gln Asn
Pro Ala Thr Trp
Pro Ala Trp Thr
Pro Asp Arg Ser
Pro Asp Ser Arg
Pro Phe Asn Pro
Pro Phe Pro Asn
Pro Ile Met Asn
C20H35N5O6S (473.23079300000006)
Pro Ile Asn Met
C20H35N5O6S (473.23079300000006)
Pro Leu Met Asn
C20H35N5O6S (473.23079300000006)
Pro Leu Asn Met
C20H35N5O6S (473.23079300000006)
Pro Met Ile Asn
C20H35N5O6S (473.23079300000006)
Pro Met Leu Asn
C20H35N5O6S (473.23079300000006)
Pro Met Asn Ile
C20H35N5O6S (473.23079300000006)
Pro Met Asn Leu
C20H35N5O6S (473.23079300000006)
Pro Met Gln Val
C20H35N5O6S (473.23079300000006)
Pro Met Val Gln
C20H35N5O6S (473.23079300000006)
Pro Asn Phe Pro
Pro Asn Ile Met
C20H35N5O6S (473.23079300000006)
Pro Asn Leu Met
C20H35N5O6S (473.23079300000006)
Pro Asn Met Ile
C20H35N5O6S (473.23079300000006)
Pro Asn Met Leu
C20H35N5O6S (473.23079300000006)
Pro Asn Pro Phe
Pro Pro Phe Asn
Pro Pro Asn Phe
Pro Gln Met Val
C20H35N5O6S (473.23079300000006)
Pro Gln Val Met
C20H35N5O6S (473.23079300000006)
Pro Arg Asp Ser
Pro Arg Ser Asp
Pro Ser Asp Arg
Pro Ser Arg Asp
Pro Thr Ala Trp
Pro Thr Trp Ala
Pro Val Met Gln
C20H35N5O6S (473.23079300000006)
Pro Val Gln Met
C20H35N5O6S (473.23079300000006)
Pro Trp Ala Thr
Pro Trp Thr Ala
Gln Ala Gln Gln
Gln Met Pro Val
C20H35N5O6S (473.23079300000006)
Gln Met Val Pro
C20H35N5O6S (473.23079300000006)
Gln Asn Asn Val
Gln Asn Val Asn
Gln Pro Met Val
C20H35N5O6S (473.23079300000006)
Gln Pro Val Met
C20H35N5O6S (473.23079300000006)
Gln Gln Ala Gln
Gln Gln Gln Ala
Gln Val Met Pro
C20H35N5O6S (473.23079300000006)
Gln Val Asn Asn
Gln Val Pro Met
C20H35N5O6S (473.23079300000006)
Arg Asp Pro Ser
Arg Asp Ser Pro
Arg Pro Asp Ser
Arg Pro Ser Asp
Arg Ser Asp Pro
Arg Ser Pro Asp
Ser Asp Pro Arg
Ser Asp Arg Pro
Ser Pro Asp Arg
Ser Pro Arg Asp
Ser Arg Asp Pro
Ser Arg Pro Asp
Thr Ala Pro Trp
Thr Ala Trp Pro
Thr Pro Ala Trp
Thr Pro Trp Ala
Thr Trp Ala Pro
Thr Trp Pro Ala
Val Met Pro Gln
C20H35N5O6S (473.23079300000006)
Val Met Gln Pro
C20H35N5O6S (473.23079300000006)
Val Asn Asn Gln
Val Asn Gln Asn
Val Pro Met Gln
C20H35N5O6S (473.23079300000006)
Val Pro Gln Met
C20H35N5O6S (473.23079300000006)
Val Gln Met Pro
C20H35N5O6S (473.23079300000006)
Val Gln Asn Asn
Val Gln Pro Met
C20H35N5O6S (473.23079300000006)
Trp Ala Pro Thr
Trp Ala Thr Pro
Trp Pro Ala Thr
Trp Pro Thr Ala
Trp Thr Ala Pro
Trp Thr Pro Ala
NBD-FTY720 phenoxy
[1-[(2-methylpropan-2-yl)oxycarbonyl]-6-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazine-1-carbonyl]indol-2-yl]boronic acid
[1-[(2-methylpropan-2-yl)oxycarbonyl]-5-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazine-1-carbonyl]indol-2-yl]boronic acid
4-[5-(2-chlorophenyl)-4-[4-(dimethylamino)phenyl]-oxazol-2-yl]-N,N-dipropyl-aniline
Simenepag isopropyl
C26H35NO5S (473.2235820000001)
C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent
2-imino-10-methyl-N-[2-(4-morpholinyl)ethyl]-5-oxo-1-(3-pyridinylmethyl)-3-dipyrido[3,4-c:1,2-f]pyrimidinecarboxamide
C25H27N7O3 (473.21752720000006)
N-[4-[[5-(3-butyl-4-oxo-1,2-dihydroquinazolin-2-yl)-2-methoxyphenyl]methoxy]phenyl]acetamide
C28H31N3O4 (473.23144460000003)
2-[2-[4-[2-Hydroxy-3-(2-methylphenoxy)propyl]-1-piperazinyl]ethyl]benzo[de]isoquinoline-1,3-dione
C28H31N3O4 (473.23144460000003)
4-[2-[(1-acetyl-4-oxo-6-spiro[3,4-dihydro-2H-1-benzopyran-2,4-piperidine]yl)oxy]-1-oxoethyl]-1-piperazinecarboxylic acid ethyl ester
(3aR,4S,9bS)-4-(hydroxymethyl)-N-(2-methoxyphenyl)-8-(4-methoxyphenyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinoline-1-carboxamide
C28H31N3O4 (473.23144460000003)
(3aS,4R,9bR)-4-(hydroxymethyl)-N-(2-methoxyphenyl)-8-(4-methoxyphenyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinoline-1-carboxamide
C28H31N3O4 (473.23144460000003)
(2S,3S,3aR,9bR)-1-(cyclopropanecarbonyl)-2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-3-(hydroxymethyl)-7-[(Z)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
C28H31N3O4 (473.23144460000003)
(2R,3R,3aS,9bS)-1-(cyclopropanecarbonyl)-2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-3-(hydroxymethyl)-7-[(Z)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
C28H31N3O4 (473.23144460000003)
Usmarapride
Usmarapride (SUVN-D4010) is a potent, selective, orally active and brain penetrant 5-HT4 receptor partial agonist (EC50=44 nM). Usmarapride (SUVN-D4010) can be used for the research of cognitive deficits associated with Alzheimer's disease[1].